CTLA4 and neoplasm: This study showed that treatments with anti-CTLA-4 antibody alone and tumour lysate-pulsed DCs alone led to increased intra-tumour infiltration of CD8+ T cells, decreased frequency of Treg cells, increased IFN-γ serum levels, reduced burden of pulmonary metastases and prolonged survival [124].